Cartography Biosciences, Inc., a biotechnology company pioneering next-generation T-cell–engaging bispecific and multispecific antibody therapeutics, announced the successful close of a $67 million Series B financing round. The new capital will be used to advance the company’s lead program, CBI-1214, into…
Monash University, Australia’s largest university and one of the world’s top 50 research institutions, has announced the launch of the Monash Boston Hub, a new strategic base designed to strengthen the university’s collaborations with North American and European biotechnology and…
55 North, the world’s largest dedicated quantum technology venture capital fund, has announced the first close of its €300 million Fund I at €134 million, marking a significant milestone for both the European and global quantum ecosystems. The fund establishes…
Genialis, the RNA biomarker company, announced a new collaboration with Cleveland Clinic, one of the world’s leading academic medical centers, to co-develop AI-driven tools that aim to personalize treatment for patients with pancreatic ductal adenocarcinoma (PDAC)—the most prevalent and deadliest…
Ideagen, a global leader in regulatory and compliance software, has announced the acquisition of SafetyStratus, a Texas-based provider of enterprise Environmental, Health and Safety (EHS) software. The move strengthens Ideagen’s growing EHSQ (Environment, Health, Safety and Quality) portfolio by introducing…
Prothena Corporation plc announced that its partner, Bristol Myers Squibb (BMS), has received Fast Track Designation from the U.S. Food and Drug Administration (FDA) for BMS-986446 (PRX005), an investigational anti-microtubule binding region-tau (anti-MTBR-tau) antibody currently in Phase 2 clinical development…
SPIE Photonics West 2026 has officially opened Registration for , the world’s largest conference and exhibition dedicated to optics and photonics. This highly anticipated global event will run from 17 to 22 January 2026 at the Moscone Center in San…
C2N Diagnostics, a recognized global leader in advanced brain health diagnostics, has taken an important step forward in the fight against Alzheimer’s disease. The company has formally submitted its innovative blood test to the U.S. Food and Drug Administration (FDA)…
Ambry Genetics, now a wholly owned subsidiary of Tempus AI, Inc. and long recognized as a pioneer in clinical genomic testing, has announced a significant enhancement to its Ambry CARE Program® (CARE). The program, a digital platform designed to streamline…
Thermo Fisher Scientific and AstraZeneca BioVentureHub Announce Strategic R&D Partnership to Advance Life Science Innovation. The PPD™ clinical research business of Thermo Fisher Scientific Inc., the world leader in serving science, today announced a new research and development (R&D) partnership…